Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)

Effect of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) among hypertensive patients with coronavirus disease 2019 (COVID-19) is debated. The aim of the COVIDECA study was to assess the outcome of ACEI and ARB among hypertensive patients presenting with CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafic, Hazrije, Fayssoil, Abdallah, Josseran, Loïc, Ouadahi, Mounir, Grimaldi-Bensouda, Lamiae, Dubourg, Olivier, Annane, Djillali, Mansencal, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895710/
https://www.ncbi.nlm.nih.gov/pubmed/33617818
http://dx.doi.org/10.1016/j.amjcard.2021.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895710/
https://www.ncbi.nlm.nih.gov/pubmed/33617818
http://dx.doi.org/10.1016/j.amjcard.2021.02.009

Ejemplares similares